Format
Sort by
Items per page

Send to

Choose Destination

Best matches for cancer genome atlas TCGA:

A Practical Guide to The Cancer Genome Atlas (TCGA). Wang Z et al. Methods Mol Biol. (2016)

The Cancer Genome Atlas Pan-Cancer analysis project. Cancer Genome Atlas Research Network. et al. Nat Genet. (2013)

Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset. Choi W et al. Eur Urol. (2017)

Search results

Items: 1 to 20 of 2763

1.

Large-scale analysis reveals a novel risk score to predict overall survival in hepatocellular carcinoma.

Zheng Y, Liu Y, Zhao S, Zheng Z, Shen C, An L, Yuan Y.

Cancer Manag Res. 2018 Nov 21;10:6079-6096. doi: 10.2147/CMAR.S181396. eCollection 2018.

PMID:
30538557
2.

High EIF2B5 mRNA expression and its prognostic significance in liver cancer: a study based on the TCGA and GEO database.

Jiao Y, Fu Z, Li Y, Meng L, Liu Y.

Cancer Manag Res. 2018 Nov 20;10:6003-6014. doi: 10.2147/CMAR.S185459. eCollection 2018.

PMID:
30538549
3.

TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients' survival.

Xiao W, Wang X, Wang T, Xing J.

Cancer Manag Res. 2018 Nov 20;10:5951-5964. doi: 10.2147/CMAR.S185270. eCollection 2018.

PMID:
30538545
4.

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.

Chen Y, Zhao J, Jiao Z, Wang W, Wang D, Yu X, Shi Z, Ge N, Pan Q, Xia J, Niu W, Zhao R, Zhang X, Du W.

BMC Cancer. 2018 Dec 11;18(1):1240. doi: 10.1186/s12885-018-5119-6.

PMID:
30537941
5.

Bioinformatic analysis of the prognostic value of the lncRNAs encoding snoRNAs in hepatocellular carcinoma.

Zhu Q, Yang H, Cheng P, Han Q.

Biofactors. 2018 Dec 8. doi: 10.1002/biof.1478. [Epub ahead of print]

PMID:
30537372
6.
7.

Integrative analysis of DNA methylation and gene expression identify a six epigenetic driver signature for predicting prognosis in hepatocellular carcinoma.

Li GX, Ding ZY, Wang YW, Liu TT, Chen WX, Wu JJ, Xu WQ, Zhu P, Zhang BX.

J Cell Physiol. 2018 Dec 7. doi: 10.1002/jcp.27882. [Epub ahead of print]

PMID:
30536816
8.

Bioinformatics analysis of the interactions among lncRNA, miRNA and mRNA expression, genetic mutations and epigenetic modifications in hepatocellular carcinoma.

Lin C, Yuan G, Hu Z, Zeng Y, Qiu X, Yu H, He S.

Mol Med Rep. 2018 Dec 5. doi: 10.3892/mmr.2018.9728. [Epub ahead of print]

PMID:
30535497
9.

High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.

Li B, Zhu J, Meng L.

Mol Med Rep. 2018 Dec 3. doi: 10.3892/mmr.2018.9716. [Epub ahead of print]

PMID:
30535476
10.

MAPT (Tau) expression is a biomarker for an increased rate of survival for low‑grade glioma.

Zaman S, Chobrutskiy BCI, Sikaria D, Blanck G.

Oncol Rep. 2018 Nov 28. doi: 10.3892/or.2018.6896. [Epub ahead of print]

PMID:
30535461
11.

Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients.

He J, Liu Y, Zhang L, Zhang H.

Med Sci Monit. 2018 Dec 10;24:8933-8940. doi: 10.12659/MSM.911518.

PMID:
30531684
12.

Correlation between EZH2 and CEP55 and lung adenocarcinoma prognosis.

Wu S, Wu D, Pan Y, Liu H, Shao Z, Wang M.

Pathol Res Pract. 2018 Nov 24. pii: S0344-0338(18)30687-3. doi: 10.1016/j.prp.2018.11.016. [Epub ahead of print]

PMID:
30527357
13.

Potential Role of microRNA-183 as a Tumor Suppressor in Hepatocellular Carcinoma.

Bian W, Zhang H, Tang M, Zhang S, Wang L, Liu L, Wang W.

Cell Physiol Biochem. 2018;51(5):2065-2072. doi: 10.1159/000495825. Epub 2018 Dec 6.

14.

Gene landscape and correlation between B-cell infiltration and programmed death ligand 1 expression in lung adenocarcinoma patients from The Cancer Genome Atlas data set.

Ho KH, Chang CJ, Huang TW, Shih CM, Liu AJ, Chen PH, Cheng KT, Chen KC.

PLoS One. 2018 Dec 6;13(12):e0208459. doi: 10.1371/journal.pone.0208459. eCollection 2018.

15.

Identification of Five Genes as a Potential Biomarker for Predicting Progress and Prognosis in Adrenocortical Carcinoma.

Xiao H, Xu D, Chen P, Zeng G, Wang X, Zhang X.

J Cancer. 2018 Oct 31;9(23):4484-4495. doi: 10.7150/jca.26698. eCollection 2018.

16.

Comprehensive Analysis of BAP1 Somatic Mutation in Clear Cell Renal Cell Carcinoma to Explore Potential Mechanisms in Silico.

Jin S, Wu J, Zhu Y, Gu W, Wan F, Xiao W, Dai B, Zhang H, Shi G, Shen Y, Zhu Y, Ye D.

J Cancer. 2018 Oct 18;9(22):4108-4116. doi: 10.7150/jca.27281. eCollection 2018.

17.

Long non-coding RNA C5orf66-AS1 promotes cell proliferation in cervical cancer by targeting miR-637/RING1 axis.

Rui X, Xu Y, Jiang X, Ye W, Huang Y, Jiang J.

Cell Death Dis. 2018 Dec 5;9(12):1175. doi: 10.1038/s41419-018-1228-z.

18.

Human papillomavirus 16 E2 regulates keratinocyte gene expression relevant to cancer and the viral life cycle.

Evans MR, James CD, Bristol ML, Nulton TJ, Wang X, Kaur N, White EA, Windle B, Morgan IM.

J Virol. 2018 Dec 5. pii: JVI.01941-18. doi: 10.1128/JVI.01941-18. [Epub ahead of print]

PMID:
30518656
19.

PDCD4 is an androgen-repressed tumor suppressor that regulates prostate cancer growth and castration resistance.

Zennami K, Choi SM, Liao R, Li Y, Dinalankara W, Marchionni L, Rafiqi FH, Kurozumi A, Hatano K, Lupold SE.

Mol Cancer Res. 2018 Dec 5. pii: molcanres.0837.2018. doi: 10.1158/1541-7786.MCR-18-0837. [Epub ahead of print]

PMID:
30518628
20.

IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.

Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J.

J Exp Clin Cancer Res. 2018 Dec 5;37(1):304. doi: 10.1186/s13046-018-0980-3.

Supplemental Content

Loading ...
Support Center